Stonebridge Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Buy
639
+307
+92% +$314K 0.37% 49
2026
Q1
$305K Buy
+332
New +$337K 0.14% 65

Other funds holding LLY

Stonebridge Capital Management's LLY Position: Q2 2026 in Review

Stonebridge Capital Management increased its Eli Lilly (LLY) stake by 92% in Q2 2026, buying an estimated $314K and bringing the position to 639 shares worth $766K. The position accounts for 0.37% of the portfolio, ranked #49.

Stonebridge Capital Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stonebridge Capital Management held 639 shares of Eli Lilly worth $766K as of Q2 2026.
  • Stonebridge Capital Management bought 307 Eli Lilly shares in Q2 2026, an estimated $314K.
  • Eli Lilly made up 0.37% of Stonebridge Capital Management's portfolio in Q2 2026, its #49 holding.
  • Stonebridge Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stonebridge Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.